An acetylation–phosphorylation switch that regulates tau aggregation propensity and function

Cryo-EM structures of tau filaments from Alzheimer’s disease

Fitzpatrick, A. W. P., Falcon, B., He, S., Murzin, A. G., Murshudov, G., Garringer, H. J., Crowther, R. A., Ghetti, B., Goedert, M., & Scheres, S. H. W. (2017) · Nature · doi:10.1038/nature23002 · Cited by 2,061 · see citing works

Tau protein isoforms, phosphorylation and role in neurodegenerative disorders11These authors contributed equally to this work.

Buée, L., Bussière, T., Buée‐Scherrer, V., Delacourte, A., & Hof, P. R. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00019-9 · Cited by 2,007 · see citing works

Alzheimer’s Disease: The Challenge of the Second Century

Holtzman, D. M., Morris, J. C., & Goate, A. M. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002369 · Cited by 1,424 · see citing works

Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease

Augustinack, J. C., Schneider, A., Mandelkow, E.-M., & Hyman, B. T. (2002) · Acta Neuropathologica · doi:10.1007/s004010100423 · Cited by 998 · see citing works

Acetylation of Tau Inhibits Its Degradation and Contributes to Tauopathy

Min, S.-W., Cho, S.-H., Zhou, Y., Schroeder, S., Haroutunian, V., Seeley, W. W., Huang, E. J., Shen, Y., Masliah, E., Mukherjee, C., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.08.044 · Cited by 949 · see citing works

Biochemistry and Cell Biology of Tau Protein in Neurofibrillary DegenerationPreprint

Mandelkow, E., & Mandelkow, E. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006247 · Cited by 839 · see citing works

Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: Distinction between PHF-like immunoreactivity and microtubule binding

Biernat, J., Gustke, N., Drewes, G., Mandelkow, E., & Mandelkow, E. (1993) · Neuron · doi:10.1016/0896-6273(93)90279-z · Cited by 796 · see citing works

CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation

Petrucelli, L. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh083 · Cited by 735 · see citing works

The acetylation of tau inhibits its function and promotes pathological tau aggregation

Cohen, T. J., Guo, J. L., Hurtado, D. E., Kwong, L. K., Mills, I. P., Trojanowski, J. Q., & Lee, V. M. Y. (2011) · Nature Communications · doi:10.1038/ncomms1255 · Cited by 724 · see citing works

The high-affinity HSP90–CHIP complex recognizes and selectively degrades phosphorylated tau client proteins

Dickey, C. A., Kamal, A., Lundgren, K., Klosak, N., Bailey, R. M., Dunmore, J., Ash, P., Shoraka, S., Zlatkovic, J., Eckman, C. B., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29715 · Cited by 642 · see citing works

Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits

Min, S.-W., Chen, X., Tracy, T. E., Li, Y., Zhou, Y., Wang, C., Shirakawa, K., Minami, S. S., Defensor, E., Mok, S. A., et al. (2015) · Nature Medicine · doi:10.1038/nm.3951 · Cited by 516 · see citing works

Tau post-translational modifications in wild-type and human amyloid precursor protein transgenic mice

Morris, M., Knudsen, G. M., Maeda, S., Trinidad, J. C., Ioanoviciu, A., Burlingame, A. L., & Mucke, L. (2015) · Nature Neuroscience · doi:10.1038/nn.4067 · Cited by 472 · see citing works

Microtubule-associated Protein/Microtubule Affinity-regulating Kinase (p110mark)

Meyer, H. E., Mandelkow, E.-M., Drewes, G., Trinczek, B., Illenberger, S., Biernat, J., Schmitt-Ulms, G., & Mandelkow, E. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.13.7679 · Cited by 388 · see citing works

Histone deacetylase 6 interacts with the microtubule‐associated protein tau

Ding, H., Dolan, P. J., & Johnson, G. V. W. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05564.x · Cited by 387 · see citing works

The CAMKK2-AMPK Kinase Pathway Mediates the Synaptotoxic Effects of Aβ Oligomers through Tau Phosphorylation

Mairet-Coello, G., Courchet, J., Pieraut, S., Courchet, V., Maximov, A., & Polleux, F. (2013) · Neuron · doi:10.1016/j.neuron.2013.02.003 · Cited by 351 · see citing works

PAR-1 Kinase Plays an Initiator Role in a Temporally Ordered Phosphorylation Process that Confers Tau Toxicity in Drosophila

Nishimura, I., Yang, Y., & Lu, B. (2004) · Cell · doi:10.1016/s0092-8674(04)00170-9 · Cited by 324 · see citing works

Alzheimer Disease-specific Conformation of Hyperphosphorylated Paired Helical Filament-Tau Is Polyubiquitinated through Lys-48, Lys-11, and Lys-6 Ubiquitin Conjugation

Cripps, D., Thomas, S. N., Jeng, Y., Yang, F., Davies, P., & Yang, A. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512786200 · Cited by 312 · see citing works

Acetylation of the KXGS motifs in tau is a critical determinant in modulation of tau aggregation and clearance

Cook, C. N., Carlomagno, Y., Gendron, T. F., Dunmore, J. H., Scheffel, K., Stetler, C. T., Davis, M., Dickson, D. W., Jarpe, M. B., Deture, M. A., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt402 · Cited by 309 · see citing works

Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies

Irwin, D. J., Cohen, T. J., Grossman, M., Arnold, S. E., Xie, S. X., Lee, V. M.-Y., & Trojanowski, J. Q. (2012) · Brain · doi:10.1093/brain/aws013 · Cited by 281 · see citing works

Akt and CHIP coregulate tau degradation through coordinated interactions

Dickey, C. A., Koren, J., Zhang, Y.-J., Xu, Y.-F., Jinwal, U. K., Birnbaum, M. J., Monks, B., Sun, M., Cheng, J. Q., Patterson, C., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709180105 · Cited by 226 · see citing works

Novel diffusion barrier for axonal retention of Tau in neurons and its failure in neurodegeneration

Li, X., Kumar, Y., Zempel, H., Mandelkow, E., Biernat, J., & Mandelkow, E. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.376 · Cited by 218 · see citing works

HSP induction mediates selective clearance of tau phosphorylated at proline-directed Ser/Thr sites but not KXGS (MARK) sites

Dickey, C. A., Dunmore, J., Lu, B., Wang, J., Lee, W. C., Kamal, A., Burrows, F., Eckman, C., Hutton, M., & Petrucelli, L. (2006) · The FASEB Journal · doi:10.1096/fj.05-5343fje · Cited by 160 · see citing works

The Development of Cell Processes Induced by tau Protein Requires Phosphorylation of Serine 262 and 356 in the Repeat Domain and Is Inhibited by Phosphorylation in the Proline-rich Domains

Biernat, J., & Mandelkow, E.-M. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.3.727 · Cited by 149 · see citing works

The microtubule-associated tau protein has intrinsic acetyltransferase activity

Cohen, T. J., Friedmann, D., Hwang, A. W., Marmorstein, R., & Lee, V. M. Y. (2013) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2555 · Cited by 149 · see citing works

Histone deacetylase 6 inhibition improves memory and reduces total tau levels in a mouse model of tau deposition

Selenica, M. B., Benner, L., Housley, S. B., Manchec, B., Lee, D. C., Nash, K. R., Kalin, J. H., Bergman, J. A., Kozikowski, A. P., Gordon, M. N., et al. (2014) · Alzheimer s Research & Therapy · doi:10.1186/alzrt241 · Cited by 142 · see citing works

Lysine methylation is an endogenous post-translational modification of tau protein in human brain and a modulator of aggregation propensity

Funk, K. E., Thomas, S. N., Schafer, K. N., Cooper, G. L., Liao, Z., Clark, D. J., Yang, A. J., & Kuret, J. (2014) · Biochemical Journal · doi:10.1042/bj20140372 · Cited by 142 · see citing works

Acetylation: a new key to unlock tau’s role in neurodegeneration

Cook, C. N., Stankowski, J. N., Carlomagno, Y., Stetler, C. T., & Petrucelli, L. (2014) · Alzheimer s Research & Therapy · doi:10.1186/alzrt259 · Cited by 133 · see citing works

Loss of HDAC6, a novel CHIP substrate, alleviates abnormal tau accumulation

Cook, C. N., Gendron, T. F., Scheffel, K., Carlomagno, Y., Dunmore, J. H., Deture, M. A., & Petrucelli, L. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds125 · Cited by 129 · see citing works

The Role of HDAC6 in Alzheimer's Disease

Zhang, L., Sheng, S., & Qin, C. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-120727 · Cited by 127 · see citing works

HDAC6 Inhibitor Blocks Amyloid Beta-Induced Impairment of Mitochondrial Transport in Hippocampal Neurons

Kim, C., Choi, H., Jung, E. S., Lee, W., Oh, S., Jeon, N. L., & Mook‐Jung, I. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042983 · Cited by 115 · see citing works

A critical role for the PAR-1/MARK-tau axis in mediating the toxic effects of Aβ on synapses and dendritic spines

Yu, W., Polepalli, J., Wagh, D., Rajadas, J., Malenka, R., & Lu, B. (2012) · Human Molecular Genetics · doi:10.1093/hmg/ddr576 · Cited by 103 · see citing works

Aging Analysis Reveals Slowed Tau Turnover and Enhanced Stress Response in a Mouse Model of Tauopathy

Dickey, C. A., Kraft, C., Jinwal, U. K., Koren, J., Johnson, A. G., Anderson, L. C., Lebson, L. A., Lee, D. C., Dickson, D. W., de Silva, R., et al. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080764 · Cited by 85 · see citing works

Tau and Synuclein and Their Role in Neuropathology

Dickson, D. W. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00548.x · Cited by 83 · see citing works

Tau deposition drives neuropathological, inflammatory and behavioral abnormalities independently of neuronal loss in a novel mouse model

Cook, C., Kang, S. S., Carlomagno, Y., Lin, W.-L., Yue, M., Kurti, A., Shinohara, M., Jansen-West, K., Perkerson, E., Castanedes-Casey, M., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv336 · Cited by 82 · see citing works

Nuclear Magnetic Resonance Analysis of the Acetylation Pattern of the Neuronal Tau Protein

Kamah, A., Huvent, I., Cantrelle, F., Qi, H., Lippens, G. M., Landrieu, I., & Smet‐Nocca, C. (2014) · Biochemistry · doi:10.1021/bi500006v · Cited by 73 · see citing works

Untitled work

(1997) · doi:10.1002/(sici)1097-4547(19970415)48:2

Novel tau filament fold in chronic traumatic encephalopathy encloses hydrophobic molecules

Falcon, B., Zivanov, J., Zhang, W., Murzin, A. G., Garringer, H. J., Vidal, R., Crowther, R. A., Newell, K. L., Ghetti, B. F., Goedert, M., et al. (2019) · Nature · doi:10.1038/s41586-019-1026-5 · Cited by 703 · see citing works

Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer’s Disease, Parkinson’s Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis

Nguyen, P. H., Ramamoorthy, A., Sahoo, B. R., Zheng, J., Faller, P., Straub, J. E., Domı́nguez, L., Shea, J., Dokholyan, N. V., Simone, A. D., et al. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01122 · Cited by 676 · see citing works

Role of Tau as a Microtubule-Associated Protein: Structural and Functional Aspects

Barbier, P., Zejneli, O., Martinho, M., Lasorsa, A., Belle, V., Smet‐Nocca, C., Tsvetkov, P. O., Devred, F., & Landrieu, I. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00204 · Cited by 623 · see citing works

Development of Multifunctional Molecules as Potential Therapeutic Candidates for Alzheimer’s Disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis in the Last Decade

Savelieff, M. G., Nam, G., Kang, J., Lee, H. J., Lee, M., & Lim, M. H. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00138 · Cited by 603 · see citing works

Phase separation and neurodegenerative diseases: a disturbance in the force

Zbinden, A., Pérez-Berlanga, M., De Rossi, P., & Polymenidou, M. (2020) · Developmental Cell · doi:10.1016/j.devcel.2020.09.014 · Cited by 500 · see citing works

Alzheimer’s disease: insights into pathology, molecular mechanisms, and therapy

Zheng, Q., & Wang, X. (2024) · Protein & Cell · doi:10.1093/procel/pwae026 · Cited by 454 · see citing works

Friend or foe—Post-translational modifications as regulators of phase separation and RNP granule dynamics

Hofweber, M., & Dormann, D. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.tm118.001189 · Cited by 389 · see citing works

The complexity of tau in Alzheimer’s disease

Naseri, N. N., Wang, H., Guo, J. D., Sharma, M., & Luo, W. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.04.022 · Cited by 374 · see citing works

Tau Post-translational Modifications: Dynamic Transformers of Tau Function, Degradation, and Aggregation

Alquezar, C., Arya, S., & Kao, A. W. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2020.595532 · Cited by 367 · see citing works

The Control Centers of Biomolecular Phase Separation: How Membrane Surfaces, PTMs, and Active Processes Regulate Condensation

Snead, W. T., & Gladfelter, A. S. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.09.016 · Cited by 355 · see citing works

Do Post-Translational Modifications Influence Protein Aggregation in Neurodegenerative Diseases: A Systematic Review

Schaffert, L.-N., & Carter, W. G. (2020) · Brain Sciences · doi:10.3390/brainsci10040232 · Cited by 165 · see citing works

Revisiting the grammar of Tau aggregation and pathology formation: how new insights from brain pathology are shaping how we study and target Tauopathies

Limorenko, G., & Lashuel, H. A. (2021) · Chemical Society Reviews · doi:10.1039/d1cs00127b · Cited by 162 · see citing works

Tau filaments in neurodegenerative diseases

Goedert, M. (2018) · FEBS Letters · doi:10.1002/1873-3468.13108 · Cited by 127 · see citing works

Acetylation changes tau interactome to degrade tau in Alzheimer’s disease animal and organoid models

Choi, H., Kim, H. J., Yang, J., Chae, S., Lee, W., Chung, S., Kim, J., Choi, H., Song, H., Lee, C. K., et al. (2019) · Aging Cell · doi:10.1111/acel.13081 · Cited by 122 · see citing works

Altered succinylation of mitochondrial proteins, APP and tau in Alzheimer’s disease

Yang, Y. S., Tapias, V., Acosta, D. M., Xu, H., Chen, H., Bhawal, R. P., Anderson, E. T., Ivanova, E., Lin, H., Sagdullaev, B. T., et al. (2022) · Nature Communications · doi:10.1038/s41467-021-27572-2 · Cited by 131 · see citing works

Protein Semisynthesis Provides Access to Tau Disease-Associated Post-translational Modifications (PTMs) and Paves the Way to Deciphering the Tau PTM Code in Health and Diseased States

Haj‐Yahya, M., & Lashuel, H. A. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b02668 · Cited by 117 · see citing works

Protein phase separation and its role in tumorigenesis

Jiang, S., Fagman, J. B., Chen, C., Alberti, S., & Liu, B. (2020) · eLife · doi:10.7554/elife.60264 · Cited by 115 · see citing works

An HDAC6-dependent surveillance mechanism suppresses tau-mediated neurodegeneration and cognitive decline

Trzeciakiewicz, H., Ajit, D., Tseng, J.-H., Chen, Y., Ajit, A., Tabassum, Z., Lobrovich, R., Peterson, C., Riddick, N. V., Itano, M. S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19317-4 · Cited by 102 · see citing works

The interactions of p53 with tau and Aß as potential therapeutic targets for Alzheimer’s disease

Jembrek, M. J., Slade, N., Hof, P. R., & Šimić, G. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.05.001 · Cited by 99 · see citing works

Hierarchical chemical determination of amyloid polymorphs in neurodegenerative disease

Li, D., & Liu, C. (2021) · Nature Chemical Biology · doi:10.1038/s41589-020-00708-z · Cited by 95 · see citing works

Small molecule therapeutics for tauopathy in Alzheimer’s disease: Walking on the path of most resistance

Wang, L., Bharti, Kumar, R., Pavlov, P. F., & Winblad, B. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112915 · Cited by 92 · see citing works

Histone deacetylases as targets for the treatment of neurodegenerative disorders: Challenges and future opportunities

Rodrigues, D. A., Pinheiro, P. D. S. M., Sagrillo, F. S., Bolognesi, M. L., & Fraga, C. A. M. (2020) · Medicinal Research Reviews · doi:10.1002/med.21701 · Cited by 72 · see citing works

Inhibition of Histone Deacetylase 6 (HDAC6) as a therapeutic strategy for Alzheimer's disease: A review (2010–2020)

Li, Y., Sang, S., Ren, W., Pei, Y., Bian, Y., Chen, Y., & Sun, H. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113874 · Cited by 77 · see citing works

The Role of Post-Translational Modifications on the Structure and Function of Tau Protein

Ye, H., Han, Y., Li, P., Su, Z., & Huang, Y. (2022) · Journal of Molecular Neuroscience · doi:10.1007/s12031-022-02002-0 · Cited by 74 · see citing works

Tau pathology reduction with SM07883, a novel, potent, and selective oral DYRK1A inhibitor: A potential therapeutic for Alzheimer's disease

Melchior, B., Mittapalli, G. K., Lai, C., Duong‐Polk, K., Stewart, J., Güner, B., Hofilena, B. J., Tjitro, A., Anderson, S., Herman, D. S., et al. (2019) · Aging Cell · doi:10.1111/acel.13000 · Cited by 73 · see citing works

Ordered Assembly of Tau Protein and Neurodegeneration

Goedert, M., & Spillantini, M. G. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9358-8_1 · Cited by 71 · see citing works

Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment

Ma, J., Huo, X., Jarpe, M. B., Kavelaars, A., & Heijnen, C. J. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0604-3 · Cited by 73 · see citing works

A Structural Ensemble of a Tau-Microtubule Complex Reveals Regulatory Tau Phosphorylation and Acetylation Mechanisms

Brotzakis, Z. F., Lindstedt, P. R., Taylor, R. J., Rinauro, D. J., Gallagher, N. C. T., Bernardes, G. J. L., & Vendruscolo, M. (2021) · ACS Central Science · doi:10.1021/acscentsci.1c00585 · Cited by 70 · see citing works

Role of Post‐translational Modifications in Alzheimer's Disease

Ramesh, M., Gopinath, P., & Govindaraju, T. (2019) · ChemBioChem · doi:10.1002/cbic.201900573 · Cited by 68 · see citing works

Degradation or aggregation: the ramifications of post-translational modifications on tau

Park, S., Lee, J. H., Jeon, J. H., & Lee, M. J. (2018) · BMB Reports · doi:10.5483/bmbrep.2018.51.6.077 · Cited by 68 · see citing works

Inhibition of HDAC6 activity protects dopaminergic neurons from alpha-synuclein toxicity

Francelle, L., Outeiro, T. F., & Rappold, G. (2020) · Scientific Reports · doi:10.1038/s41598-020-62678-5 · Cited by 60 · see citing works

Crosstalk between protein post-translational modifications and phase separation

Liu, Y., Feng, W., Wang, Y.-S., & Wu, B. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-023-01380-1 · Cited by 59 · see citing works

Cell-specific role of histone deacetylase 6 in chemotherapy-induced mechanical allodynia and loss of intraepidermal nerve fibers

Ma, J., Trinh, R. T. P., Mahant, I., Peng, B., Matthias, P., Heijnen, C. J., & Kavelaars, A. (2019) · Pain · doi:10.1097/j.pain.0000000000001667 · Cited by 57 · see citing works

Enhanced identification of Tau acetylation and phosphorylation with an engineered aerolysin nanopore

Huo, M., Hu, Z., Ying, Y., & Long, Y. (2021) · PROTEOMICS · doi:10.1002/pmic.202100041 · Cited by 56 · see citing works

TSC1 loss increases risk for tauopathy by inducing tau acetylation and preventing tau clearance via chaperone-mediated autophagy

Alquezar, C., Schoch, K. M., Geier, E. G., Ramos, E. M., Scrivo, A., Li, K. H., Argouarch, A. R., Mlynarski, E. E., Dombroski, B., DeTure, M., et al. (2021) · Science Advances · doi:10.1126/sciadv.abg3897 · Cited by 56 · see citing works

Inhibition of SIRT2 promotes APP acetylation and ameliorates cognitive impairment in APP/PS1 transgenic mice

Bai, N., Li, N., Cheng, R., Guan, Y., Zhao, X., Song, Z., Xu, H., Yi, F., Jiang, B., Li, X., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111062 · Cited by 56 · see citing works

Distinct Conformers of Assembled Tau in Alzheimer's and Pick's DiseasesPreprint

Goedert, M., Falcon, B., Zhang, W., Ghetti, B. F., & Scheres, S. H. W. (2018) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2018.83.037580 · Cited by 56 · see citing works

Regulation of RNA granules by FMRP and implications for neurological diseases

Lai, A., Valdez‐Sinon, A. N., & Bassell, G. J. (2020) · Traffic · doi:10.1111/tra.12733 · Cited by 53 · see citing works

Single Posttranslational Modifications in the Central Repeat Domains of Tau4 Impact its Aggregation and Tubulin Binding

Ellmer, D., Brehs, M., Haj‐Yahya, M., Lashuel, H. A., & Becker, C. F. W. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201805238 · Cited by 50 · see citing works

Histone deacetylase-6 modulates Tau function in Alzheimer's disease

Qureshi, T., & Chinnathambi, S. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2022.119275 · Cited by 49 · see citing works

An acetylation mimicking mutation, K274Q, in tau imparts neurotoxicity by enhancing tau aggregation and inhibiting tubulin polymerization

Rane, J. S., Kumari, A. R., & Panda, D. (2019) · Biochemical Journal · doi:10.1042/bcj20190042 · Cited by 47 · see citing works

New insights into the heat responses of grape leaves via combined phosphoproteomic and acetylproteomic analyses

Liu, G., Jiang, J., Liu, X., Jiang, J., Sun, L., Duan, W., Li, R., Wang, Y., Lecourieux, D., Liu, C., et al. (2019) · Horticulture Research · doi:10.1038/s41438-019-0183-x · Cited by 46 · see citing works

Restoring the epigenome in Alzheimer's disease: advancing HDAC inhibitors as therapeutic agents

Pereira, M. S., Cruz, M. T., Fortuna, A. C., & Bicker, J. (2024) · Drug Discovery Today · doi:10.1016/j.drudis.2024.104052 · Cited by 44 · see citing works

The Contribution and Therapeutic Potential of Epigenetic Modifications in Alzheimer’s Disease

Wood, I. C. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00649 · Cited by 43 · see citing works

Phase separation in plants: New insights into cellular compartmentalization

Xu, X., Zheng, C., Lu, D., Song, C., & Zhang, L. (2021) · Journal of Integrative Plant Biology · doi:10.1111/jipb.13152 · Cited by 43 · see citing works

MPT0G612, a Novel HDAC6 Inhibitor, Induces Apoptosis and Suppresses IFN-γ-Induced Programmed Death-Ligand 1 in Human Colorectal Carcinoma Cells

Chen, M.-C., Lin, Y., Liao, Y.-H., Liou, J., & Chen, C. (2019) · Cancers · doi:10.3390/cancers11101617 · Cited by 41 · see citing works

Translation of HDAC6 PET Imaging Using [18F]EKZ-001–cGMP Production and Measurement of HDAC6 Target Occupancy in Nonhuman Primates

Celen, S., Rokka, J., Gilbert, T. M., Koole, M. J. B., Vermeulen, I., Serdons, K., Schroeder, F. A., Wagner, F. F., Bleeser, T., Hightower, B. G., et al. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00074 · Cited by 40 · see citing works

Acetylation-mediated remodeling of the nucleolus regulates cellular acetyl-CoA responses

Houston, R., Sekine, S., Calderon, M. J., Seifuddin, F., Wang, G., Kawagishi, H., Malide, D. A., Li, Y., Guček, M., Pirooznia, M., et al. (2020) · PLoS Biology · doi:10.1371/journal.pbio.3000981 · Cited by 37 · see citing works

Tau exhibits unique seeding properties in globular glial tauopathy

Chung, D. C., Carlomagno, Y., Cook, C. N., Jansen‐West, K. R., Daughrity, L. M., Lewis‐Tuffin, L. J., Castanedes‐Casey, M., Deture, M. A., Dickson, D. W., & Petrucelli, L. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0691-9 · Cited by 37 · see citing works

Multiplexed Phosphoproteomic Study of Brain in Patients with Alzheimer's Disease and Age-Matched Cognitively Healthy Controls

Sathe, G. J., Mangalaparthi, K. K., Jain, A., Darrow, J. A., Troncoso, J. C., Albert, M., Moghekar, A., & Pandey, A. (2020) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2019.0191 · Cited by 36 · see citing works

Post-translational modifications within tau paired helical filament nucleating motifs perturb microtubule interactions and oligomer formation

Acosta, D. M., Mancinelli, C. D., Bracken, C., & Eliezer, D. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101442 · Cited by 35 · see citing works

Tau Seeding Mouse Models with Patient Brain-Derived Aggregates

Robert, A., Schöll, M., & Vogels, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116132 · Cited by 35 · see citing works

Clinical validation of the novel HDAC6 radiotracer [18F]EKZ-001 in the human brain

Koole, M. J. B., Weehaeghe, D. V., Serdons, K., Herbots, M., Cawthorne, C., Celen, S., Schroeder, F. A., Hooker, J. M., Bormans, G. M., Hoon, J. N. J. M. D., et al. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-04891-y · Cited by 33 · see citing works

Tau K321/K353 pseudoacetylation within KXGS motifs regulates tau–microtubule interactions and inhibits aggregation

Xia, Y., Bell, B. M., & Giasson, B. I. (2021) · Scientific Reports · doi:10.1038/s41598-021-96627-7 · Cited by 33 · see citing works

The roles of intrinsically disordered proteins in neurodegeneration

Utami, K. H., Morimoto, S., Mitsukura, Y., & Okano, H. (2025) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2025.130772 · Cited by 34 · see citing works

Tau Filaments and the Development of Positron Emission Tomography Tracers

Goedert, M., Yamaguchi, Y., Mishra, S. K., Higuchi, M., & Sahara, N. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00070 · Cited by 31 · see citing works

A unique tau conformation generated by an acetylation-mimic substitution modulates P301S-dependent tau pathology and hyperphosphorylation

Ajit, D., Trzeciakiewicz, H., Tseng, J., Wander, C. M., Chen, Y., Ajit, A., King, D. P., & Cohen, T. J. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.009674 · Cited by 31 · see citing works

Complicated Role of Post-translational Modification and Protease-Cleaved Fragments of Tau in Alzheimer’s Disease and Other Tauopathies

Yang, J., Shen, N., Shen, J., Yang, Y., & Li, H.-L. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03867-x · Cited by 32 · see citing works

Post-Translational Modifications in Tau and Their Roles in Alzheimer's Pathology

Kalyaanamoorthy, S., Opare, S. K. A., Xu, X., Ganesan, A., & Rao, P. P. N. (2024) · Current Alzheimer Research · doi:10.2174/0115672050301407240408033046 · Cited by 31 · see citing works

Structure-Based Drug Designing Recommends HDAC6 Inhibitors To Attenuate Microtubule-Associated Tau-Pathogenesis

Zeb, A., Park, C., Rampogu, S. D., Son, M., Lee, G., & Lee, K. W. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00405 · Cited by 30 · see citing works

The Class IV human deacetylase, HDAC11, exhibits anti‐influenza A virus properties via its involvement in host innate antiviral response

Nutsford, A. N., Galvin, H. D., Ahmed, F., & Husain, M. (2018) · Cellular Microbiology · doi:10.1111/cmi.12989 · Cited by 30 · see citing works

An Emerging Role for Post-translational Modifications in Regulating RNP Condensates in the Germ Line

Schisa, J. A., & Elaswad, M. T. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.658020 · Cited by 27 · see citing works

A Distinct Tau Code Controlled by HDAC6 is Linked to Tau Pathogenesis and the Neuronal Stress Response

Tseng, J., Ajit, A., Tabassum, Z., Patel, N., Tian, X., Chen, Y., Prevatte, A. W., Ling, K., Rigo, F., Meeker, R. B., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2021.109037 · Cited by 26 · see citing works

Monoclonal antibody Y01 prevents tauopathy progression induced by lysine 280–acetylated tau in cell and mouse models

Song, H.-L., Kim, N.-Y., Park, J., Kim, M. I., Jeon, Y.-N., Lee, S.-J., Cho, K., Shim, Y.-L., Lee, K.-H., Mun, Y.-S., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci156537 · Cited by 26 · see citing works

The Structure Biology of Tau and Clue for Aggregation Inhibitor Design

Wang, D., Huang, X., Yan, L., Zhou, L., Chang, Y., Wu, J., Su, Z., & Huang, Y. (2021) · The Protein Journal · doi:10.1007/s10930-021-10017-6 · Cited by 26 · see citing works

Neuroepigenetics and Alzheimer’s Disease: An Update

Zusso, M., Barbierato, M., Facci, L., Skaper, S. D., & Giusti, P. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180259 · Cited by 27 · see citing works

Central inhibition of HDAC6 re-sensitizes leptin signaling during obesity to induce profound weight loss

Guan, D., Men, Y., Bartlett, A., Hernández, M. A. S., Xu, J., Yi, X., Li, H.-S., Kong, D., Mazitschek, R., & Özcan, U. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.02.007 · Cited by 25 · see citing works

Regulation of Functional Protein Aggregation by Multiple Factors: Implications for the Amyloidogenic Behavior of the CAP Superfamily Proteins

Sheng, J., Olrichs, N. K., Gadella, B. M., Kaloyanova, D. V., & Helms, J. B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186530 · Cited by 25 · see citing works

Early neurotransmission impairment in non-invasive Alzheimer Disease detection

Peña‐Bautista, C., Torres-Cuevas, I., Baquero, M., Ferrer, I., García, L., Vento, M., & Cháfer‐Pericás, C. (2020) · Scientific Reports · doi:10.1038/s41598-020-73362-z · Cited by 25 · see citing works

Drug Discovery for Histone Deacetylase Inhibition: Past, Present and Future of Zinc-Binding Groups

Pires, G. S., Tolomeu, H. V., Rodrigues, D. A., Lima, L. M., Fraga, C. A. M., & Pinheiro, P. D. S. M. (2025) · Pharmaceuticals · doi:10.3390/ph18040577 · Cited by 25 · see citing works

Modulation of Tau Pathology in Alzheimer’s Disease by Dietary Bioactive Compounds

Shi, H., & Zhao, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020831 · Cited by 24 · see citing works

Clinical relevance of biomarkers, new therapeutic approaches, and role of post-translational modifications in the pathogenesis of Alzheimer’s disease

Mumtaz, I., Ayaz, M. O., Khan, M. S., Manzoor, U., Ganayee, M. A., Bhat, A. Q., Dar, G. H., Alghamdi, B. S. A., Hashem, A. M., Dar, M. J., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.977411 · Cited by 22 · see citing works

Pan-HDAC Inhibitors Promote Tau Aggregation by Increasing the Level of Acetylated Tau

Jeong, H., Shin, S., Lee, J., Lee, S. H., Baik, J., Lim, S., & Kim, Y. K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174283 · Cited by 22 · see citing works

Post-Translational Modifications Control Phase Transitions of Tau

Powell, W. C., Nahum, M., Pankratz, K., Herlory, M., Greenwood, J., Poliyenko, D., Holland, P., Jing, R., Biggerstaff, L., Stowell, M. H. B., et al. (2024) · ACS Central Science · doi:10.1021/acscentsci.4c01319 · Cited by 19 · see citing works

The human brain acetylome reveals that decreased acetylation of mitochondrial proteins associates with Alzheimer's disease

Sun, L., Bhawal, R. P., Xu, H., Chen, H., Anderson, E. T., Haroutunian, V., Cross, A. C., Zhang, S., & Gibson, G. E. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15377 · Cited by 19 · see citing works

A hybrid approach unveils drug repurposing candidates targeting an Alzheimer pathophysiology mechanism

Lage‐Rupprecht, V., Schultz, B. T., Dick, J., Namysł, M., Zaliani, A., Gebel, S., Pleß, O., Reinshagen, J., Ellinger, B., Ebeling, C., et al. (2022) · Patterns · doi:10.1016/j.patter.2021.100433 · Cited by 19 · see citing works

Tau acetylation at K280 regulates tau phosphorylation

Kim, M.-S., Mun, Y., Lee, S., Cho, W.-Y., Han, S.-H., Kim, D., & Yoon, S. (2022) · International Journal of Neuroscience · doi:10.1080/00207454.2022.2081165 · Cited by 19 · see citing works

Acetylation and phosphorylation processes modulate Tau’s binding to microtubules: A molecular dynamics study

Castro, T. G., Ferreira, T., Matamá, T., Munteanu, F., & Cavaco-Paulo, A. M. (2022) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2022.130276 · Cited by 18 · see citing works

Histone deacetylase inhibition mitigates cognitive deficits and astrocyte dysfunction induced by amyloid‐β (Aβ) oligomers

Morgado, J., Diniz, L. P., Araújo, A. P. B., Antônio, L. M. D. S., Mota-Araujo, H. P., Pinheiro, P. D. S. M., Sagrillo, F. S., Vargas, G., Ferreira, S. T., Figueiredo, C. P., et al. (2024) · British Journal of Pharmacology · doi:10.1111/bph.16439 · Cited by 17 · see citing works

Untangling Tau: Molecular Insights into Neuroinflammation, Pathophysiology, and Emerging Immunotherapies

Davidson, R., Krider, R. I., Borsellino, P., Noorda, K., Alhwayek, G., & Vida, T. A. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45110553 · Cited by 17 · see citing works

Molecular Insights into the Differential Effects of Acetylation on the Aggregation of Tau Microtubule-Binding Repeats

Zou, Y. F., Guan, L., Tan, J., Qi, B., Sun, Y., Huang, F., & Zhang, Q. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.3c01929 · Cited by 16 · see citing works

The Role of Methionine Residues in the Regulation of Liquid-Liquid Phase Separation

Aledo, J. (2021) · Biomolecules · doi:10.3390/biom11081248 · Cited by 13 · see citing works

Regulation of Tau Homeostasis and Toxicity by Acetylation

Tracy, T. E., Claiborn, K. C., & Gan, L. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9358-8_4 · Cited by 16 · see citing works

Structure-based prediction of HDAC6 substrates validated by enzymatic assay reveals determinants of promiscuity and detects new potential substrates

Varga, J. K., Diffley, K., Leng, K. W., Fierke, C. A., & Schueler‐Furman, O. (2022) · Scientific Reports · doi:10.1038/s41598-022-05681-2 · Cited by 15 · see citing works

SIRT3-and FAK-mediated acetylation-phosphorylation crosstalk of NFATc1 regulates Nε-carboxymethyl-lysine-induced vascular calcification in diabetes mellitus

Sun, Z., Zhang, L., Yin, K., Zang, G., Qian, Y., Mao, X., Li, L., Jing, Q., & Wang, Z. (2023) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2023.06.969 · Cited by 14 · see citing works

Oxidative Stress Conditions Result in Trapping of PHF-Core Tau (297–391) Intermediates

Maina, M. B., Al‐Hilaly, Y. K., Burra, G., Rickard, J. E., Harrington, C. R., Wischik, C. M., & Serpell, L. C. (2021) · Cells · doi:10.3390/cells10030703 · Cited by 14 · see citing works

Single Posttranslational Modifications in the Central Repeat Domains of Tau4 Impact its Aggregation and Tubulin Binding

Ellmer, D., Brehs, M., Haj‐Yahya, M., Lashuel, H. A., & Becker, C. F. W. (2018) · Angewandte Chemie · doi:10.1002/ange.201805238 · Cited by 13 · see citing works

Elevated SGK1 increases Tau phosphorylation and microtubule instability in Alzheimer’s patient-derived cortical neurons

Saleem, K., Xiao, Z., Zhu, B., Ren, Y., Yan, Z., & Feng, J. (2026) · Molecular Psychiatry · doi:10.1038/s41380-025-03225-4 · Cited by 10 · see citing works

Succinylation Links Metabolic Reductions to Amyloid and Tau PathologyPreprint

Yang, Y., Tapias, V., Acosta, D. M., Xu, H., Chen, H., Bhawal, R. P., Anderson, E., Ivanova, E., Lin, H., Sagdullaev, B. T., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/764837 · Cited by 10 · see citing works

Biochemical approaches to assess the impact of post-translational modifications on pathogenic tau conformations using recombinant protein

Alhadidy, M. M., & Kanaan, N. M. (2024) · Biochemical Society Transactions · doi:10.1042/bst20230596 · Cited by 9 · see citing works

Histone deacetylase’s regulates Tau function in Alzheimer’s disease

Chinnathambi, S. (2024) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2024.09.008 · Cited by 9 · see citing works

The Regulatory Mechanism of Transthyretin Irreversible Aggregation through Liquid-to-Solid Phase Transition

Duan, G., Li, Y., Ye, M., Liu, H., Wang, N., & Luo, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043729 · Cited by 9 · see citing works

Binding of inhibitors to active-site mutants of CD1, the enigmatic catalytic domain of histone deacetylase 6

Osko, J. D., & Christianson, D. W. (2020) · Acta Crystallographica Section F Structural Biology Communications · doi:10.1107/s2053230x20010250 · Cited by 9 · see citing works

Diverse influences on tau aggregation and implications for disease progressionPreprint

Alstyne, M. V., Pratt, J., & Parker, R. (2025) · Genes & Development · doi:10.1101/gad.352551.124 · Cited by 10 · see citing works

Decoding tau acetylation in Alzheimer’s disease and tauopathies: from site-specific mechanisms to therapeutic horizons

Oh, Y. R., & Shin, M. (2025) · BMB Reports · doi:10.5483/bmbrep.2025-0077 · Cited by 9 · see citing works

Comprehensive review on Alzheimer's disease: From the posttranslational modifications of Tau to corresponding treatments

Li, X., Ba, Z., Huang, J., Chen, J., Jiang, J., Huang, N., & Luo, Y. (2024) · Ibrain · doi:10.1002/ibra.12176 · Cited by 7 · see citing works

Therapeutic potential of dual HDAC6/SIRT2 inhibition in Alzheimer's disease

Wang, X., Li, C., Chen, L., He, B., & Li, Y. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117733 · Cited by 8 · see citing works

The double‐edged sword effect of HDAC6 in Aβ toxicities

Cheng, K., Hwang, Y., & Chiang, H. (2021) · The FASEB Journal · doi:10.1096/fj.202101061r · Cited by 7 · see citing works

Design, synthesis and pharmacological evaluation of multitarget GPR40 agonists/HDAC6 inhibitors for Alzheimer’s disease

Pinheiro, P. D. S. M., Chirico, F. D., Loi, M., Trazzi, S., Ciani, E., Rodrigues, D. A., Alves, M. A., Lima, L. M., Milelli, A., Monti, B., et al. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117868 · Cited by 6 · see citing works

Acetylation Mimetic and Null Mutations Within the Filament Core of P301L Tau Have Varied Effects on Susceptibility to Seeding and Aggregation

Smith, E. D., Torrellas, J., McKenna, R., Vo, Q., Mietzsch, M., Borchelt, D., Prokop, S., & Chakrabarty, P. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70221 · Cited by 6 · see citing works

THE REGULATION OF TAU PATHOGENESIS IN NEURODEGENERATION

Trzeciakiewicz, H. (2020) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/xwcc-h138

The acetylation of tau inhibits its function and promotes pathological tau aggregation

Cohen, T. J., Guo, J. L., Hurtado, D. E., Kwong, L. K., Mills, I. P., Trojanowski, J. Q., & Lee, V. M. Y. (2011) · Nature Communications · doi:10.1038/ncomms1255 · Cited by 724 · see citing works

Acetylation: a new key to unlock tau’s role in neurodegeneration

Cook, C. N., Stankowski, J. N., Carlomagno, Y., Stetler, C. T., & Petrucelli, L. (2014) · Alzheimer s Research & Therapy · doi:10.1186/alzrt259 · Cited by 133 · see citing works

Acetylation of the KXGS motifs in tau is a critical determinant in modulation of tau aggregation and clearance

Cook, C. N., Carlomagno, Y., Gendron, T. F., Dunmore, J. H., Scheffel, K., Stetler, C. T., Davis, M., Dickson, D. W., Jarpe, M. B., Deture, M. A., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt402 · Cited by 309 · see citing works

An HDAC6-dependent surveillance mechanism suppresses tau-mediated neurodegeneration and cognitive decline

Trzeciakiewicz, H., Ajit, D., Tseng, J.-H., Chen, Y., Ajit, A., Tabassum, Z., Lobrovich, R., Peterson, C., Riddick, N. V., Itano, M. S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19317-4 · Cited by 102 · see citing works